Pediatrix Medical Group (MD) Stock: Buy, Sell, or Hold?
MD - Pediatrix Medical Group, Inc.
$29.55
1.45 (5.16%)
▲
5d:
+6.45%
30d:
+14.27%
90d:
+12.53%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Oct 29, 2026
5d
Get Alerted When MD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: MD shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: MD shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$29.70
Based on 4.0% avg growth
INTRINSIC VALUE TODAY
$18.44
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MD is currently trading at $29.55, which is considered extended relative to its 30-day fair value range of $25.65 to $27.47. From a valuation perspective, the stock is trading at a premium (Forward PE: 12.1) compared to its historical average (10.0). At these levels, the market is pricing in 6.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MD is in a uptrend. The price is approaching resistance at $29.68. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.2% recently.
Market Sentiment: MD scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $26.33. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MD is in a uptrend. The price is approaching resistance at $29.68. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.2% recently.
Market Sentiment: MD scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $26.33. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$25.65 -
$27.47
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
18.1%
All Signals
- BEARISH: Price extended above range (+7.6% above its trading range)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.2%)
- BEARISH: Trading 10.9% above Wall St target ($26.33)
- NEUTRAL: Trading at premium valuation - market expects 6.5% growth which is achievable
- WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$25.65 -
$27.47
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$26.33
Resistance Level
$29.69
Current Trend
Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.10
Wall Street Target
$26.33
(-10.9%)
Revenue Growth (YoY)
4.0%
Earnings Growth (YoY)
6.5%
Profit Margin
9.0%
Valuation Premium vs History
+6.5% premium
PE vs Historical
12.1 vs 10.0
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.5%
(market-implied from PE analysis)
1-Year Target
$31.47
(+7%)
2-Year Target
$33.52
(+13%)
3-Year Target
$35.69
(+21%)
3-Yr Target (if PE normalizes)
(PE: 12→10)
PE COMPRESSION
$29.49
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 4.0%)
$54.47
(+84%)
Base:
(SPY PE: 12.1, Growth: 4.0%)
$33.20
(+12%)
Bear:
(PE: 10.0, Growth: 4.0%)
$27.43
(-7%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (13x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 13.45 | Current EPS (TTM): $2.09
Bull Case
$36.11
(+22%)
Analyst growth 16.8%, PE expands to 14.8
Base Case
$32.82
(+11%)
Market implied 16.8%, PE stable at 13.5
Bear Case
$19.11
(-35%)
Severe decline -20.0%, PE contracts to 11.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 22, 2026 8:03 PM ET
Data refreshes hourly during market hours. Next update: 9:03 PM
Data refreshes hourly during market hours. Next update: 9:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
23 analysts |
$286 | 54 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$461 | 50 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 61 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
13 analysts |
$148 | 60 HOLD |
|
GRDN
Guardian Pharmacy Servic… |
STRONG BUY
7 analysts |
$50 | 60 BUY |
